Accelerated approval Phase IV commitments
Executive Summary
FDA's Oncologic Drugs Advisory Committee will meet Nov. 8 to review unfulfilled Phase IV commitments of accelerated approval oncologic drug products. The committee will "identify difficulties associated with completion" of the commitments and provide "advice to sponsors to assist in the planning and execution of postmarketing commitments of newly approved drugs," FDA says. The status of Phase IV commitments for Johnson & Johnson/Alza's Doxil, MedImmune's Ethyol, Ligand/Seragen's Ontak, SkyePharma's DepoCyt, Pfizer's Celebrex, Wyeth's Mylotarg, and Genzyme/Ilex' Campath will be reviewed. Office of Oncology Drugs Director Richard Pazdur said there would be a meeting on the topic during the Sept. 14 review of GlaxoSmithKline's Arranon (1"The Pink Sheet" Sept. 26, 2005, p. 27). The meeting will be held at the Holiday Inn in Gaithersburg, Md. beginning at at 8 a.m.[Editor's Note: To 2watch a webcastor order a video/DVD of this meeting, visit FDAAdvisoryCommittee.com]...
You may also be interested in...
Oncology Advisory Cmte. To Review Unfulfilled Accelerated Approval Trials
FDA's Oncologic Drugs Advisory Committee will review products with unfulfilled accelerated approval postmarketing commitments during an upcoming meeting
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.